Download PDF
Thromb Haemost 1991; 65(01): 067-072
DOI: 10.1055/s-0038-1647456
Original Article
Schattauer GmbH Stuttgart

Role of Active Center and Lysine Binding Sites of Plasmin in Plasmin-Induced Platelet Activation and Disaggregation

He Lu
INSERM U 150, Institutdes Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France, Faculté de Médecine et de Pharmacie, Université de Haute Normandie, Rouen, France
,
Claudine Soria
INSERM U 150, Institutdes Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France, Faculté de Médecine et de Pharmacie, Université de Haute Normandie, Rouen, France
,
Hong Li
INSERM U 150, Institutdes Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France, Faculté de Médecine et de Pharmacie, Université de Haute Normandie, Rouen, France
,
Jeannette Soria
**   Laboratoire Sainte Marie, Hôtel Dieu, Paris, France
,
H Roger Lijnen
*   Center for Thrombosis and Vascular Research, University of Leuven, Leuven, Belgium
,
Jean Y Perrot
**   Laboratoire Sainte Marie, Hôtel Dieu, Paris, France
,
Jacques P Caen
INSERM U 150, Institutdes Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France, Faculté de Médecine et de Pharmacie, Université de Haute Normandie, Rouen, France
› Author Affiliations
Further Information

Publication History

Received 11 June 1990

Accepted after revision 03 August 1990

Publication Date:
04 September 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Previous studies have shown that plasmin can activate platelets and - can also disperse platelet aggregates by degradation of fibrinogen bound to platelets. In this study, the role of the active center and the lysine binding sites (LBS) of human plasmin in activating platelets and in dispersing platelet aggresates is investigated using aprotinin and the tripeptide Val-Phe-Lys-CH2Cl to inhibit the active center and using epsilon-aminocaproic acid (EACA) to specifically block the LBS. Our results show that the catalytic activity of plasmin is indispensable both for activating platelets and for dispersing platelet aggregates. Binding of plasmin to platelets through the LBS enhances its activating potential, since both EACA (1 mM) and Lys-plasminogen (molar ratio of plasminogen:plasmin at 2:l to 4:1) inhibit plasmininduced platelet activation, whereas Glu-plasminogen at a molar ratio of 15: I had no effect. Furthermore, plasmin which lacks the LBS (miniplasmin), is about 3 fold less effective in activating platelets. Flowever, plasmin binding through the LBS is not absolutely required to disperse platelet aggregates, since EACA at 30 mmol/l was unable to prevent disaggregation by plasmin (half disaggregation time: 40 min in the presence of EACA against 27 min in its absence). It also appeared that fibrinogen receptors on activated platelets are resistant to plasmin degradation, and that disaggregation of plasmin-induced platelet aggregates was much slower than the degradation of fibrinogen by plasmin.

 

  • References

  • 1 Niewiarowski S, Senyi AF, Gillies P. Plasmin-induced platelet activation and release reaction. Effect on hemostasis. J Clin Invest 1973; 52: 1647-1659
    PubMedGoogle Scholar
  • 2 Miller JL, Katz AJ, Feinstein MB. Plasmin inhibition of thrombin-induced platelet aggregation. Thromb Diathes Haemorrh 1975; 33: 286-309
    PubMedGoogle Scholar
  • 3 Schafer AI, Adelman B. Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest 1985; 75: 456-461
    CrossrefPubMedGoogle Scholar
  • 4 Guccione MA, Kinlough-Rathbone RL, Packham MA, Harfenist EJ, Rand ML, Greenberg JP, Perry DW, Mustard JF. Effects of plasmin on rabbit platelets. Thromb Haemostas 1985; 53: 8-14
    PubMedGoogle Scholar
  • 5 Adnot S, Ferry N, Hanoune J, Lacombe ML. Plasmin: a possible physiological modulator of the human platelet adenylate cyclase system. Clin Sci 1987; 72: 467-473
    CrossrefPubMedGoogle Scholar
  • 6 Loscalzo J. Platelet and thrombolysis. J Vase Med Biol 1989; 1: 213-219
    PubMedGoogle Scholar
  • 7 Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990; 322: 33-42
    CrossrefPubMedGoogle Scholar
  • 8 Schafer AI, Maas AN, Ware JA, Johnson PC, Rittenhouse SE, Salzman EW. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. J Clin Invest 1986; 78: 73-79
    CrossrefPubMedGoogle Scholar
  • 9 Greenberg J, Orr JL, Packman MA, Guccione MA, Harfenist EJ, Kinglough-Rathbone RL, Perry DW, Mustard JF. The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood 1979; 54: 753-765
    PubMedGoogle Scholar
  • 10 Niewiarowski S, Budzynski AZ, Morinelli TA, Brudzynnski TM, Stewart GJ. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem 1979; 256: 917-925
    PubMedGoogle Scholar
  • 11 Lu H, Soria C, Cramer EM, Soria J, Perrot JY, Li H, Commin PL, Schumann F, Regnier O, Lijnen HR, Caen JP. Temperature dependence of plasmin-induced activation or inhibition of human platelet. Blood (in press)
    PubMedGoogle Scholar
  • 12 Rudd MA, Amarante P, Smick D, Vaughan DE, Loscalzo J. Temporal effects of tissue plasminogen activator infusion on platelet aggregation ex vivo. Blood 1988; 72 (Suppl. 01) 374A (Abstr)
    PubMedGoogle Scholar
  • 13 Jang IK, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, May JW, Collen D. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to thrombolysis. Circulation 1989; 79: 920-928
    PubMedGoogle Scholar
  • 14 Loscalzo J, Vaughan C. Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest 1987; 79: 1749-1755
    CrossrefPubMedGoogle Scholar
  • 15 Castellino FJ. Biochemistry of human plasminogen. Semin Thromb Haemostas 1984; 10: 18-23
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Lucas MA, Fretto LJ. The binding of plasminogen to fibrin and fibrinogen. J Biol Chem 1983; 258: 4249-4256
    PubMedGoogle Scholar
  • 17 Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303-4311
    PubMedGoogle Scholar
  • 18 Adelman B, Rizk A, Hanners E. Plasminogen interacts with platelets in plasma. Blood 1988; 72: 1530-1535
    PubMedGoogle Scholar
  • 19 Adelman B, Michelson AD, Greenberg J, Handin R. Proteolysis of platelet glycoprotein Ib by plasmin is facilitated by plasmin lysine-binding regions. Blood 1986; 68: 1280-1284
    CrossrefPubMedGoogle Scholar
  • 20 Vaughan DE, Mendelsohn ME, Declerck PJ, Van Houtte EV, Loscalzo J. Characterization of the binding of human tissue-type plasminogen activator to platelets. J Biol Chem 1989; 264: 15869-15874
    PubMedGoogle Scholar
  • 21 Park S, Harker LA, Marzec UM, Levin EG. Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane. Blood 1989; 73: 1421-1425
    CrossrefPubMedGoogle Scholar
  • 22 Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and the cell surface: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-2420
    CrossrefPubMedGoogle Scholar
  • 23 Wiman B, Boman L, Collen D. On the kinetics of the reaction between human antiplasmin and a low molecular weight form of plasmin. Eur J Biochem 1978; 87: 143-146
    CrossrefPubMedGoogle Scholar
  • 24 Patscheke H, Womer P. Platelet activation detected by turbidimetric shape-change analysis. Thrombolysis Res 1978; 12: 485-496
    PubMedGoogle Scholar
  • 25 Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein Ilb/IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-11114
    CrossrefPubMedGoogle Scholar
  • 26 Larsen E, Celi A, Gibert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312
    CrossrefPubMedGoogle Scholar
  • 27 Wiman B. On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or α1-antiplasmin. Thromb Res 1980; 17: 143-152
    CrossrefPubMedGoogle Scholar
  • 28 Collen D, Lijnen HR, De Cock F, Durieux JP, Loffet A. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinase. Biochim Biophys Acta 1980; 165: 158-166
    PubMedGoogle Scholar
  • 29 Okamoto S, Okamoto U, Okada Y, Hijikata-Okunomiya A, Wanaka K, Horie N, Naito T. Coding, decoding and noise of proteinase: a rational approach to plasmin inhibitors. In: Fundamental and Clinical Fibrinolysis Castellino FJ. (ed). Elsevier Science Publishers; Amsterdam: 1987: 67-82
  • 30 Christensen U, Sottrup-Jensen L, Magnusson S, Petersen TE, Clemmensen J. Enzymatic properties of the neoplasmin-Val442 (mini-plasmin). Biochim Biophys Acta 1979; 567: 472-481
    PubMedGoogle Scholar
  • 31 Sottrup-Jensen L, Claeys H, Lajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen Isolation of two lysine-binding fragments and one “mini-plasminogen” (Mw 38,000) by elastase catalysed specific limited proteolysis. In: Progress in Chemical Fibrinolysis and Thrombolysis Davidson JF, Roman RM, Samama MM. (eds). Raven Press; New York: 1978. 3 139-209
  • 32 Caen JP, Larrieu MJ, Samama MM. L’Hemostase, méthodes d’exploration et de diagnostic pratique. L’Expansion scientifique francaise Paris: 1975
    Google Scholar
  • 33 Marguierie G, Plow EF. The fibrinogen-dependent pathway of platelet aggregation. Ann NY Acad Sci 1983; 408: 556-566
    CrossrefPubMedGoogle Scholar
  • 34 Harfenist EJ, Packhan MA, Kinlough-Rathbone RL, Mustard JI. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. J Lab Clin Med 1981; 97: 680-688
    PubMedGoogle Scholar
  • 35 Peerschke EI B. Decreased accessibility of platelet-bound fibrinogen to antibody and enzyme probes. Blood 1989; 74: 682-689
    PubMedGoogle Scholar
  • 36 Nachman RL, Silverstein RL, Asch AS. Thrombospondin: Cell biology of an adhesive glycoprotein. In: Thrombosis and Haemostasis Verstraete M, Vermylen J, Lijnen R, Arnout J. (eds). Leuven University Press; Leuven: 1987: 81-91
  • 37 Parise LV, Phillips DR. Fibronectin-binding properties of the purified platelet glycoprotein Ilb/IIIa complex. J Biol Chem 1986; 261: 14011-14020
    PubMedGoogle Scholar
  • 38 Plow EF, Sroujia AH, Meyer D, Marguerie G, Ginsberg MH. Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem 1984; 259: 5388-5391
    PubMedGoogle Scholar
  • 39 Kastrikina TF, Taran LD, Kudinov SA. Kinetic characteristics of fibrinogen and fibrin hydrolysis by plasmin 1 and 2 and miniplasmin. Thromb Res 1986; 41: 681-688
    CrossrefPubMedGoogle Scholar
  • 40 Morris JP, Castellino FG. The role of the lysine binding sites of human plasmin in the hydrolysis of human fibrinogen. Biochim Biophys Acta 1983; 744: 93-104
    PubMedGoogle Scholar